Search

Your search keyword '"Maher, Lisa A."' showing total 94 results

Search Constraints

Start Over You searched for: Author "Maher, Lisa A." Remove constraint Author: "Maher, Lisa A." Database Supplemental Index Remove constraint Database: Supplemental Index
94 results on '"Maher, Lisa A."'

Search Results

2. Socioeconomic consequences of the COVID‐19 pandemic for people who use drugs

3. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis

4. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know.

5. “There’s No Sense to It”: A Posthumanist Ethnography of Agency in Methamphetamine Recovery

6. ‘Making Ground’:An Ethnography of ‘Living With’ Harmful Methamphetamine Use and the Plurality of Recovery

7. JCL Roundtable: Global Think Tank on Lipoprotein(a).

8. Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluation

9. Young Aboriginal people's sexual health risk reduction strategies: a qualitative study in remote Australia.

10. High hepatitis C virus infection among female sex workers in Viet Nam: strong correlation with HIV and injection drug use.

11. Technological Change and Economy in the Epipalaeolithic: Assessing the Shift from Early to Middle Epipalaeolithic at Kharaneh IV.

12. Intensive sex partying with gamma-hydroxybutyrate: factors associated with using gamma-hydroxybutyrate for chemsex among Australian gay and bisexual men - results from the Flux Study.

14. Patient, staffing and health centre factors associated with annual testing for sexually transmissible infections in remote primary health centres.

16. Factors Associated with Non-Adherence to HBV Antiviral Therapy

18. Hepatitis C virus prevalence and associated risk factors among Indigenous Australians who inject drugs

19. High chlamydia and gonorrhoea repeat positivity in remote Aboriginal communities 2009-2011: longitudinal analysis of testing for re-infection at 3 months suggests the need for more frequent screening.

21. HIV treatment cascade among female entertainment and sex workers in Cambodia: impact of amphetamine use and an HIV prevention program

22. Adherence to Hepatitis B Antiviral Therapy

23. Reasons for delays in treatment of bacterial sexually transmissible infections in remote Aboriginal communities in Australia: a qualitative study of healthcentre staff.

24. Sexual risk and healthcare seeking behaviour in young Aboriginal and Torres Strait Islander people in North Queensland.

25. Sexual behaviour, drug use and health service use by young Noongar people in Western Australia: a snapshot.

26. Conflicting Rights: How the Prohibition of Human Trafficking and Sexual Exploitation Infringes the Right to Health of Female Sex Workers in Phnom Penh, Cambodia.

27. Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used?

28. Barriers and facilitators of sexually transmissible infection testing in remote Australian Aboriginal communities: results from the Sexually Transmitted Infections in Remote Communities, Improved and Enhanced Primary Health Care (STRIVE) Study.

30. WOMEN IN THE STREET-LEVEL DRUG ECONOMY: CONTINUITY OR CHANGE?

31. Factors associated with HBV Virological Breakthrough

32. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees

33. Current practices and barriers to the use of facemasks and respirators among hospital-based health care workers in Vietnam.

34. Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study.

35. Surveillance of injecting‐related injury and diseases in people who inject drugs attending a targeted primary health care facility in Sydney's Kings Cross

36. Surveillance of injecting‐related injury and diseases in people who inject drugs attending a targeted primary health care facility in Sydney's Kings Cross

37. 3. Contrasting Crime General and Crime Specific Theory: The Case of Hot spots of Crime.

38. DMP VI: Preliminary results from 2009 fieldwork on the human prehistory the Libyan Sahara.

39. DMP III: Pleistocene and Holocene palaeonvironments and prehistoric occupation of Fazzan, Libyan Sahara.

40. WHAT PUBLIC POLICIES AFFECT HEROIN USERS?

41. Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction

42. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs

43. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs

48. Is subacute care worth your money?

49. Notions of Injecting Drug Users' Candidacy for Hepatitis C Treatment: Conflicting Provider, Patient, and Public Health Perspectives

50. The effectiveness of harm reduction in preventing HIV among injecting drug users

Catalog

Books, media, physical & digital resources